Sfoglia per Autore
Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure
2015 Onesti, CONCETTA ELISA; Romiti, Adriana; Roberto, Michela; Falcone, Rosa; Marchetti, Paolo
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer
2016 Borro, Marina; Botticelli, Andrea; Mazzuca, Federica; Onesti, Elisa Concetta; Gentile, Giovanna; Romiti, Adriana; Cerbelli, Bruna; Mazzotti, Eva; Marchetti, Luca; Lionetto, Luana; Simmaco, Maurizio; Marchetti, Paolo
A rare case of palatin tonsillar metastasis from small cell lung cancer
2016 D'Antonio, Chiara; Lombardini, Alberto; Onesti, CONCETTA ELISA; Falcone, Rosa; Romiti, Adriana; Lombardi, Marianna; Lauro, Salvatore; Marchetti, Paolo
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
2016 Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art
2016 Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano
Evolving treatments for advanced gastric cancer: appraisal of the survival trend
2016 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; Zullo, Angelo; Falcone, Rosa; Marchetti, Paolo
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer
2016 Romiti, Adriana; Roberto, Michela; D'Antonio, Chiara; Onesti, CONCETTA ELISA; Barucca, Viola; Milano, Annalisa; Gentile, Giovanna; Lionetto, Luana; Medda, Emanuela; Mazzuca, Federica; Botticelli, Andrea; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis
2016 Romiti, Adriana; Rulli, Eliana; Pilozzi, Emanuela; Gerardi, Chiara; Roberto, Michela; Legramandi, Lorenzo; Falcone, Rosa; Pacchetti, Ilaria; Marchetti, Paolo; Floriani, Irene
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker?
2016 Botticelli, Andrea; Borro, Marina; Onesti, CONCETTA ELISA; Strigari, Lidia; Gentile, Giovanna; Cerbelli, Bruna; Romiti, Adriana; Occhipinti, Mario; Sebastiani, Claudia; Lionetto, Luana; Marchetti, Luca; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine
2017 Roberto, Michela; Romiti, Adriana; Botticelli, Andrea; Mazzuca, Federica; Lionetto, Luana; Gentile, Giovanna; Paris, Ida; Falcone, Rosa; Bassanelli, Maria; DI PIETRO, FRANCESCA ROMANA; Onesti, CONCETTA ELISA; Anselmi, Elisabetta; Macrini, Serena; Simmaco, Maurizio; Marchetti, Paolo
Current achievements and future perspectives of metronomic chemotherapy
2017 Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
Tackling pancreatic cancer with metronomic chemotherapy
2017 Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
Impact of tumor site on the prognosis of small bowel adenocarcinoma
2019 Falcone, Rosa; Romiti, Adriana; Filetti, Marco; Roberto, Michela; Righini, Riccardo; Botticelli, Andrea; Pilozzi, Emanuela; Ghidini, Michele; Pizzo, Claudio; Mazzuca, Federica; Marchetti, Paolo
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours
2019 Roberto, M.; Arrivi, G.; Milano, A.; D’Antonio, C.; Romiti, A.; Falcone, R.; Mazzuca, F.; Fais, S.; Marchetti, P.
Study of histopathologic parameters to define the prognosis of stage II colon cancer
2019 Romiti, A.; Roberto, M.; Marchetti, P.; Di Cerbo, A.; Falcone, R.; Campisi, G.; Ferri, M.; Balducci, G.; Ramacciato, G.; Ruco, L.; Pilozzi, E.
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial
2020 Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure | 2015 | Onesti, CONCETTA ELISA; Romiti, Adriana; Roberto, Michela; Falcone, Rosa; Marchetti, Paolo | |
| Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer | 2016 | Borro, Marina; Botticelli, Andrea; Mazzuca, Federica; Onesti, Elisa Concetta; Gentile, Giovanna; Romiti, Adriana; Cerbelli, Bruna; Mazzotti, Eva; Marchetti, Luca; Lionetto, Luana; Simmaco, Maurizio; Marchetti, Paolo | |
| A rare case of palatin tonsillar metastasis from small cell lung cancer | 2016 | D'Antonio, Chiara; Lombardini, Alberto; Onesti, CONCETTA ELISA; Falcone, Rosa; Romiti, Adriana; Lombardi, Marianna; Lauro, Salvatore; Marchetti, Paolo | |
| 5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX | 2016 | Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art | 2016 | Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano | |
| Evolving treatments for advanced gastric cancer: appraisal of the survival trend | 2016 | Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; Zullo, Angelo; Falcone, Rosa; Marchetti, Paolo | |
| The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer | 2016 | Romiti, Adriana; Roberto, Michela; D'Antonio, Chiara; Onesti, CONCETTA ELISA; Barucca, Viola; Milano, Annalisa; Gentile, Giovanna; Lionetto, Luana; Medda, Emanuela; Mazzuca, Federica; Botticelli, Andrea; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo | |
| Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis | 2016 | Romiti, Adriana; Rulli, Eliana; Pilozzi, Emanuela; Gerardi, Chiara; Roberto, Michela; Legramandi, Lorenzo; Falcone, Rosa; Pacchetti, Ilaria; Marchetti, Paolo; Floriani, Irene | |
| Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker? | 2016 | Botticelli, Andrea; Borro, Marina; Onesti, CONCETTA ELISA; Strigari, Lidia; Gentile, Giovanna; Cerbelli, Bruna; Romiti, Adriana; Occhipinti, Mario; Sebastiani, Claudia; Lionetto, Luana; Marchetti, Luca; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine | 2017 | Roberto, Michela; Romiti, Adriana; Botticelli, Andrea; Mazzuca, Federica; Lionetto, Luana; Gentile, Giovanna; Paris, Ida; Falcone, Rosa; Bassanelli, Maria; DI PIETRO, FRANCESCA ROMANA; Onesti, CONCETTA ELISA; Anselmi, Elisabetta; Macrini, Serena; Simmaco, Maurizio; Marchetti, Paolo | |
| Current achievements and future perspectives of metronomic chemotherapy | 2017 | Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
| Tackling pancreatic cancer with metronomic chemotherapy | 2017 | Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
| Impact of tumor site on the prognosis of small bowel adenocarcinoma | 2019 | Falcone, Rosa; Romiti, Adriana; Filetti, Marco; Roberto, Michela; Righini, Riccardo; Botticelli, Andrea; Pilozzi, Emanuela; Ghidini, Michele; Pizzo, Claudio; Mazzuca, Federica; Marchetti, Paolo | |
| Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours | 2019 | Roberto, M.; Arrivi, G.; Milano, A.; D’Antonio, C.; Romiti, A.; Falcone, R.; Mazzuca, F.; Fais, S.; Marchetti, P. | |
| Study of histopathologic parameters to define the prognosis of stage II colon cancer | 2019 | Romiti, A.; Roberto, M.; Marchetti, P.; Di Cerbo, A.; Falcone, R.; Campisi, G.; Ferri, M.; Balducci, G.; Ramacciato, G.; Ruco, L.; Pilozzi, E. | |
| Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial | 2020 | Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile